South Korea's Celltrion builds Hong Kong biosimilar JV Vcell aimed at Chinese market July 22, 2019 By Jihyun Kim No Comments HONG KONG – Celltrion Inc., of South Korea, and Hong Kong-based conglomerate Nan Fung Group Holdings Ltd. said they have built a joint venture named Vcell Healthcare Ltd., geared toward the Chinese market. Read More